Press Releases

 

All Releases | Reset Search
Acquisitions | Business/Product | Corporate | Financial

2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006
DateTitle 
12/20/12Hospira to Host Conference Call for Fourth-Quarter 2012 Results and 2013 ProjectionsPrinter Friendly Version
12/10/12Hospira to Present at the J.P. Morgan 31st Annual Healthcare Conference Jan. 8, 2013Printer Friendly Version
11/07/12Hospira Reports Third-Quarter 2012 ResultsPrinter Friendly Version
10/18/12Statement on Drug Shortages and Quality Commitment by Hospira CEO Mike BallPrinter Friendly Version
10/05/12Hospira to Host Conference Call for Third-quarter 2012 ResultsPrinter Friendly Version
08/30/12Hospira to Present at the UBS Global Life Sciences Conference Sept. 20, 2012Printer Friendly Version
08/29/12Hospira to Acquire Active Pharmaceutical Ingredient Manufacturing and R&D FacilitiesPrinter Friendly Version
08/14/12Hospira to Present at Upcoming Investor ConferencesPrinter Friendly Version
08/09/12Hospira Announces U.S. Re-Launch Of Generic Oxaliplatin InjectionPrinter Friendly Version
08/01/12Hospira Reports Second-Quarter 2012 ResultsPrinter Friendly Version
07/31/12Hospira Expands Board of Directors With Election of Dennis M. FentonPrinter Friendly Version
06/29/12Hospira to Host Conference Call for Second-quarter 2012 ResultsPrinter Friendly Version
06/29/12Hospira and Lancaster General Hospital Honored for Patient Safety InitiativesPrinter Friendly Version
06/11/12Hospira Introduces Enhanced TheraDoc™ Clinical Surveillance System to Help Hospitals Improve Patient Outcomes and Better Manage Antibiotic UsePrinter Friendly Version
05/24/12I.V. Clinical Integration Helps Deliver Safety, Efficiency And Financial Benefits; Hospira Shares Snapshot Of Results, ProcessPrinter Friendly Version
05/21/12 Hospira Announces Important Safety Information Regarding Carpuject Syringe System and the Potential For OverfillPrinter Friendly Version
05/09/12Hospira Convenes Its 2012 Annual Meeting of ShareholdersPrinter Friendly Version
05/08/12Hospira to Present at Upcoming Investor ConferencesPrinter Friendly Version
05/01/12Hospira Reports First-Quarter 2012 ResultsPrinter Friendly Version
04/26/12Hospira to Present at the Bank of America Merrill Lynch 2012 Health Care ConferencePrinter Friendly Version
04/12/12Hospira Infusion Pumps Ranked Top Devices in New KLAS Smart Pumps 2012 ReportPrinter Friendly Version
04/11/12Hospira Names John B. Elliot Senior Vice President of OperationsPrinter Friendly Version
04/02/12Hospira to Host Conference Call for First-quarter 2012 ResultsPrinter Friendly Version
03/09/12Hospira's TheraDoc(TM) Clinical Surveillance System to Support Infection Prevention and Patient Safety Efforts at CHRISTUS HealthPrinter Friendly Version
03/08/12Hospira Receives FDA Clearance for Symbiq(TM) 3.13 Infusion PumpPrinter Friendly Version
02/23/12Hospira Joins the Generic Pharmaceutical AssociationPrinter Friendly Version
02/22/12Hospira to Present at the Barclays Capital Global Healthcare ConferencePrinter Friendly Version
02/21/12Hospira Works With FDA to Help Avert Methotrexate Shortage; Shipping One Month's Supply of New Product Immediately and on Track to Ensure Sustainable SupplyPrinter Friendly Version
02/14/12Hospira Working With Urgency to Help Address Methotrexate ShortagePrinter Friendly Version
02/14/12Hospira Reports Fourth-Quarter and Full-Year 2011 ResultsPrinter Friendly Version
02/13/12Hospira Names Zena G. Kaufman Senior Vice President of Quality; Strengthens Quality and Compliance Capabilities With Addition of Top Industry TalentPrinter Friendly Version
02/10/12Hospira Commends FDA on Draft Biosimilars GuidelinesPrinter Friendly Version
01/30/12Hospira Names Richard Davies Chief Commercial OfficerPrinter Friendly Version
01/19/12Hospira named a Top 50 Organization for Multicultural Business OpportunitiesPrinter Friendly Version
01/16/12Hospira to Host Conference Call for Fourth-Quarter 2011 Results and 2012 ProjectionsPrinter Friendly Version
01/09/12Hospira Announces Start of U.S. Phase III Biosimilar EPO Clinical ProgramPrinter Friendly Version